FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2034221490> ?p ?o ?g. }

• W2034221490 endingPage "418" @default.
• W2034221490 startingPage "410" @default.
• W2034221490 abstract "Aims Bortezomib (Velcade®), a novel proteasome inhibitor, has shown promise in the treatment of malignancies, including multiple myeloma and non-Hodgkin's lymphoma. Several studies have identified neuropathy as a potentially dose-limiting side effect of treatment with bortezomib. We report the clinical and electrodiagnostic data from four patients who developed signs and symptoms of peripheral neuropathy from treatment with bortezomib. Materials and methods Patients were included if they were enrolled in active phase 2 trials of bortezomib for non-Hodgkin's lymphoma or prostate cancer, developed signs and symptoms of peripheral neuropathy, and were referred for electrodiagnostic evaluation. Results Four patients, including two with non-Hodgkin's lymphoma and two with prostate cancer, underwent electrodiagnostic testing. Electrodiagnostic evaluation showed pre-existing peripheral nervous system disorders in three out of four patients. Multiple peripheral nervous system disorders were present in two out of four patients. Conclusions Bortezomib can cause a predominately sensory axonal polyneuropathy. Pre-existing peripheral nervous system disorders, such as neuropathy and radiculopathy, are common in patients with cancer, and may pre-dispose to the development of symptomatic neuronal toxicity when treated with bortezomib. Baseline electrodiagnostic evaluation may identify patients with pre-existing peripheral nervous system disorders at risk for additive neuronal toxicity from neurotoxic chemotherapeutic agents." @default.
• W2034221490 created "2016-06-24" @default.
• W2034221490 creator A5002126535 @default.
• W2034221490 creator A5005126836 @default.
• W2034221490 creator A5027165899 @default.
• W2034221490 creator A5034783996 @default.
• W2034221490 creator A5037979752 @default.
• W2034221490 creator A5039147214 @default.
• W2034221490 creator A5040722301 @default.
• W2034221490 creator A5059956572 @default.
• W2034221490 creator A5072850546 @default.
• W2034221490 date "2006-06-01" @default.
• W2034221490 modified "2023-10-17" @default.
• W2034221490 title "An Electrodiagnostic Evaluation of the Effect of Pre-existing Peripheral Nervous System Disorders in Patients Treated with the Novel Proteasome Inhibitor Bortezomib" @default.
• W2034221490 cites W1964956799 @default.
• W2034221490 cites W1987679181 @default.
• W2034221490 cites W2001888004 @default.
• W2034221490 cites W2002134258 @default.
• W2034221490 cites W2004607766 @default.
• W2034221490 cites W2004857153 @default.
• W2034221490 cites W2008813393 @default.
• W2034221490 cites W2017976511 @default.
• W2034221490 cites W2020399135 @default.
• W2034221490 cites W2026016034 @default.
• W2034221490 cites W2043405547 @default.
• W2034221490 cites W2058530230 @default.
• W2034221490 cites W2066350187 @default.
• W2034221490 cites W2068667916 @default.
• W2034221490 cites W2089039897 @default.
• W2034221490 cites W2100608938 @default.
• W2034221490 cites W2102109465 @default.
• W2034221490 cites W2108235071 @default.
• W2034221490 cites W2113883225 @default.
• W2034221490 cites W2411602300 @default.
• W2034221490 cites W4211137409 @default.
• W2034221490 cites W4255729497 @default.
• W2034221490 doi "https://doi.org/10.1016/j.clon.2005.12.008" @default.
• W2034221490 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16817333" @default.
• W2034221490 hasPublicationYear "2006" @default.
• W2034221490 type Work @default.
• W2034221490 sameAs 2034221490 @default.
• W2034221490 citedByCount "20" @default.
• W2034221490 countsByYear W20342214902012 @default.
• W2034221490 countsByYear W20342214902013 @default.
• W2034221490 countsByYear W20342214902014 @default.
• W2034221490 countsByYear W20342214902017 @default.
• W2034221490 countsByYear W20342214902021 @default.
• W2034221490 crossrefType "journal-article" @default.
• W2034221490 hasAuthorship W2034221490A5002126535 @default.
• W2034221490 hasAuthorship W2034221490A5005126836 @default.
• W2034221490 hasAuthorship W2034221490A5027165899 @default.
• W2034221490 hasAuthorship W2034221490A5034783996 @default.
• W2034221490 hasAuthorship W2034221490A5037979752 @default.
• W2034221490 hasAuthorship W2034221490A5039147214 @default.
• W2034221490 hasAuthorship W2034221490A5040722301 @default.
• W2034221490 hasAuthorship W2034221490A5059956572 @default.
• W2034221490 hasAuthorship W2034221490A5072850546 @default.
• W2034221490 hasConcept C121608353 @default.
• W2034221490 hasConcept C126322002 @default.
• W2034221490 hasConcept C134018914 @default.
• W2034221490 hasConcept C143998085 @default.
• W2034221490 hasConcept C2775892965 @default.
• W2034221490 hasConcept C2776364478 @default.
• W2034221490 hasConcept C2777478702 @default.
• W2034221490 hasConcept C2778367456 @default.
• W2034221490 hasConcept C2779338263 @default.
• W2034221490 hasConcept C2779901536 @default.
• W2034221490 hasConcept C2780192828 @default.
• W2034221490 hasConcept C46762472 @default.
• W2034221490 hasConcept C529278444 @default.
• W2034221490 hasConcept C545314008 @default.
• W2034221490 hasConcept C555293320 @default.
• W2034221490 hasConcept C71924100 @default.
• W2034221490 hasConceptScore W2034221490C121608353 @default.
• W2034221490 hasConceptScore W2034221490C126322002 @default.
• W2034221490 hasConceptScore W2034221490C134018914 @default.
• W2034221490 hasConceptScore W2034221490C143998085 @default.
• W2034221490 hasConceptScore W2034221490C2775892965 @default.
• W2034221490 hasConceptScore W2034221490C2776364478 @default.
• W2034221490 hasConceptScore W2034221490C2777478702 @default.
• W2034221490 hasConceptScore W2034221490C2778367456 @default.
• W2034221490 hasConceptScore W2034221490C2779338263 @default.
• W2034221490 hasConceptScore W2034221490C2779901536 @default.
• W2034221490 hasConceptScore W2034221490C2780192828 @default.
• W2034221490 hasConceptScore W2034221490C46762472 @default.
• W2034221490 hasConceptScore W2034221490C529278444 @default.
• W2034221490 hasConceptScore W2034221490C545314008 @default.
• W2034221490 hasConceptScore W2034221490C555293320 @default.
• W2034221490 hasConceptScore W2034221490C71924100 @default.
• W2034221490 hasIssue "5" @default.
• W2034221490 hasLocation W20342214901 @default.
• W2034221490 hasLocation W20342214902 @default.
• W2034221490 hasOpenAccess W2034221490 @default.
• W2034221490 hasPrimaryLocation W20342214901 @default.
• W2034221490 hasRelatedWork W1732928399 @default.
• W2034221490 hasRelatedWork W1868029912 @default.
• W2034221490 hasRelatedWork W1973074169 @default.
• W2034221490 hasRelatedWork W2120081884 @default.

• next